Quel est le prix pour Roche Holding AG (RO)

Le prix pour Roche Holding AG (RO) est $481.73

Quelle est la capitalisation boursière pour Roche Holding AG (RO)

La capitalisation boursière pour Roche Holding AG (RO) est $377.65B

Bénéfices de Roche Holding AG (RO)

Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.

Année	Bénéfices	Changez
Pas assez de données pour les dates fournies.

Année

Bénéfices

Changez

Pas assez de données pour les dates fournies.

Entreprise	Bénéfices	Différence de bénéfices	Pays
Eli Lilly and Company LLY.US	$33.59B	57.07%	US
Johnson & Johnson JNJ.US	$25.20B	17.80%	US
AbbVie Inc. ABBV.US	$8.70B	-59.33%	US
Merck & Co., Inc. MRK.US	$5.95B	-72.19%	US
Novartis AG NOVN.SW	$16.38B	-23.42%	CH

Entreprise

Bénéfices

Différence de bénéfices

Pays